- Home
- PROV vs HLVX Comparison
PROV vs HLVX Comparison
Compare PROV & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- HLVX
- Stock Information
- Founded
- PROV 1956
- HLVX 2020
- Country
- PROV United States
- HLVX United States
- Employees
- PROV N/A
- HLVX N/A
- Industry
- PROV Savings Institutions
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- PROV Finance
- HLVX Health Care
- Exchange
- PROV Nasdaq
- HLVX Nasdaq
- Market Cap
- PROV 107.5M
- HLVX 92.6M
- IPO Year
- PROV 1996
- HLVX 2022
- Fundamental
- Price
- PROV $14.79
- HLVX $1.82
- Analyst Decision
- PROV Hold
- HLVX Hold
- Analyst Count
- PROV 1
- HLVX 5
- Target Price
- PROV $16.00
- HLVX $2.33
- AVG Volume (30 Days)
- PROV 4.0K
- HLVX 172.5K
- Earning Date
- PROV 04-28-2025
- HLVX 05-08-2025
- Dividend Yield
- PROV 3.79%
- HLVX N/A
- EPS Growth
- PROV N/A
- HLVX N/A
- EPS
- PROV 0.91
- HLVX N/A
- Revenue
- PROV $38,443,000.00
- HLVX N/A
- Revenue This Year
- PROV $2.30
- HLVX N/A
- Revenue Next Year
- PROV $9.89
- HLVX N/A
- P/E Ratio
- PROV $16.27
- HLVX N/A
- Revenue Growth
- PROV N/A
- HLVX N/A
- 52 Week Low
- PROV $12.01
- HLVX $1.55
- 52 Week High
- PROV $16.70
- HLVX $18.42
- Technical
- Relative Strength Index (RSI)
- PROV 32.39
- HLVX 48.82
- Support Level
- PROV $14.65
- HLVX $1.78
- Resistance Level
- PROV $15.24
- HLVX $1.91
- Average True Range (ATR)
- PROV 0.27
- HLVX 0.07
- MACD
- PROV -0.09
- HLVX 0.01
- Stochastic Oscillator
- PROV 11.20
- HLVX 40.82
Stock Price Comparison Chart: PROV vs HLVX
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.